Osteoprotegerin, which is a member of the tumor necrosis factor receptor superfamily and is involved in the regulation of bone metabolism. OPGand its ligand (OPGL) are cytokines regulating osteoclasto-genesis. OPGL binds to receptors on the surface of preosteoclasts and stimulates their differentiation into active osteoclasts. This leads to osteoresorption. OPG inhibits this osteoclasto-genesis (OPG is secreted by osteoblasts, and binds to OPGL, thus inhibiting maturation of osteoclasts and osteoresorption). The degree and activity of osteoresorption depend mainly on the balance between OPG and its ligand (OPGL); factors increasing OPGL expression mostly reduce OPG expression and vice versa.
1. Effects of hypolipemic drugs on the osteoprotegerin - sRANKL system in patients with coronary artery disease. Thromb Haemost 2007 May;97(5):868-70
- Product Reviews
- Product Publications
If you've used this product in a publication, let us know. Email email@example.com, with the publication details and you could be eligible for an Amazon gift card.
- Related Products
Name Catalog # Size BMP-2 PR15013 10 ug BMP-2 PR27023 10 ug BMP-2 PR27023 2 ug BMP-2 (E. coli-expressed), CF PR15014CF 10 ug BMP-2 (E.coli-expressed) PR15014 10 ug BMP-2, CF PR15013CF 10 ug BMP-4 PR15015 10 ug BMP-4 PR27024 10 ug BMP-4 PR27024 2 ug BMP-4, CF PR15015CF 10 ug BMP-7 PR27026 10 ug BMP-7 PR27026 2 ug BMP-7 CHO PR27001 10 ug BMP-7 CHO PR27001 2 ug GDF-5 PR27028 10 ug GDF-5 PR27028 50 ug Noggin PR27117 20 ug Noggin PR27117 5 ug Noggin/Fc Chimera, Carrier Free PR15070CF 50 ug Pleiotrophin/OSF-1 PR27119 20 ug Pleiotrophin/OSF-1 PR27119 5 ug